Submission of the manuscript is online via e-mail
ecgarticle@gmail.com or
cholerez@mail.ru

Tel: +7 903 250 5288

Editorial Correspondence e-mail
gastrossr@gmail.com


Publishing, Subscriptions, Sales and Advertising, Correspondence e-mail
journal@cniig.ru

Tel: +7 917 561 9505

SCImago Journal & Country Rank

    1. Clinical Hospital № 122 them L. G. Sokolova, St. Petersburg, Russia
    2. SPb St. Mary Magdalene Children’s City Hospital № 2, St. Petersburg, Russia
    3. St. Petersburg State Pediatric Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia
    4. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia

    Keywords: food hypersensitivity, diet, an individual diet, ulcerative colitis, inflammatory bowel disease, the methods of selection of the diet for ulcerative colitis, prevention of exacerbations of ulcerative colitis

    Abstract: Allergic reactions to foods can occur in any one of four major types of reactions [P. Gell, R. Coombs].The most typical combination of several types of reactions, one patient. Food antigens can modify cellular and humoral immune response by influencing the emergence of new and for chronic diseases. Objective: to study the spectrum of food sensitization in patients with diseases of the digestive system (DDS) to adjust their dietary therapy. The laboratory examination and treatment of 210 patient: 185 patients with DDS (gastroesophageal reflux disease, chronic gastroduodenitis, biliary dyskinesia, irritable bowel syndrome, IBD (ulcerative colitis(UC) and Crohn’s disease) and 25 healthy adults. To identify the reactions I, III and IY-type food allergens used a range of methods - ELISA (IgE-specific) and the reaction of inhibition of migration of leukocytes (RIML), modification NN Matyshevoy and LS Kositsky. Products that implement positive reactions, patients were excluded from the diet. 100% of patients identified specific reactions I, III and IY-type food allergy, the number of responses increased in proportion to the severity of the disease, most patients with IBD, the smallest - in healthy individuals. Exclusion from the diet of the identified potential allergens contributed to a significant clinical improvement, and in patients with UC onset of persistent clinical and endoscopic remission. Conclusion: to determine the most complete range of food sensitization in patients with DDS is necessary to use methods for assessing cellular and humoral sensitization types together. Diet exclusion of food allergens from the diet of patients with DDS leads to persistent clinical improvement and long-term maintenance of remission, especially in patients with UC.

      1. Beyer K, Niggemann B. Food allergy in childhood. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016, Jun; 59 (6): 732-736.
      2. Lin CH. Food allergy: what it is and what it is not? Curr Opin Gastroenterol. 2018 Dec 17. DOI: 10.1097/MOG.0000000000000506.
      3. Gurina O. P., Dement’eva E.A., Blinov A. E., Varlamova O. N., Timohina V. I. Features of the immune response in chronic gastrointestinal diseases in children., 2014, 3-4: M3-M4. (In Russ.)
      4. Bel’mer S.V., Razumovskij A.YU., Havkin A. I., Alhasov A. B., Bekhtereva M. K., Volynec G. V., et al. Bowel disease in children. Moscow: MEDPRAKTIKA-M, 2018; 2: 496. (In Russ.)
      5. Pearlman M, Akpotaire O. Diet and the Role of Food in Common Gastrointestinal Diseases. Med Clin North Am. 2019 Jan; 103, (1):101-110. DOI: 10.1016/j.mcna.2018.08.008. Review.
      6. Mitin YA. Laboratory diagnosis of allergic diseases. Guidelines. Saint Petersburg; 2010: 144 p. (In Russ.)
      7. DeGeeter C, Guandalini S. Food Sensitivities: Fact Versus Fiction. Gastroenterol Clin North Am. 2018 Dec; 47(4): 895-908. DOI: 10.1016/j.gtc.2018.07.012. Epub 2018 Oct 5. Review.
      8. Kryukova O. A., Matysheva N. N., Drygin A. N. Food sensitization in patients with diseases of the digestive system. Pediatr. 2018; 9 (5): 27-35 (In Russ.)
      9. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of the NIAID-Sponsored Expert Panel // J Allergy Clin Immunol. 2010; V. 126, № 6.
      10. Ardatskaya M. D., Bel’mer S.V., Dobrica V. P., Zaharenko S. M., et al. Colon dysbacteriosis (dysbiosis): modern state of the problem, comprehensive diagnosis and treatment correction. Experimental and Clinical Gastroenterology. 2015;5(117):13-50. (In Russ.)
      11. Novik G. A., Tkachenko M. A. Gastrointestinal manifestations of food allergies in children. Practitioner. 2012; (1): 16-25. (In Russ.)
      12. Novikova V. P., Bogdanova N. M. Probiotics in children intestinal diseases therapy. Experimental and Clinical Gastroenterology. 2016;12 (136):78-83. (In Russ.)
      13. Zaslavskij D. V., Novikova V. P., CHuprov I.N., Sydikov A. A., et al. Probiotics in the prevention and treatment of atopic dermatitis in children. Voprosy prakticheskoj pediatrii 2016, Vol. 11, no. 2, pp. 51-57. (In Russ.)
      14. Reddavide R, Rotolo O, Caruso MG, Stasi E, Notarnicola M, Miraglia C, Nouvenne A, Meschi T, De’ Angelis GL, Di Mario F, Leandro G. The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. Acta Biomed. 2018 Dec 17;89(9-S):60-75. DOI: 10.23750/abm.v89i9-S.7952.
      15. Aleksandrova K, Romero-Mosquera B, Hernandez V. Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.Nutrients. 2017 Aug 30;9(9). pii: E962. DOI: 10.3390/nu9090962. Review.
      16. Gurina O. P., Dement’eva E.A., Blinov A. E., Varlamova O. N., Blinov G. A. Immunological profile in children with Crohn’s disease. Medicinskaya immunologiya. 2017, Vol. 19, no. S, p. 159. (In Russ.)
      17. Havkin A. I., Komarova O. N. Functional disorders of the digestive system in children and microbiota. Voprosy prakticheskoj pediatrii. 2017, Vol. 12, no 3, pp. 54-62. (In Russ.)
      18. Novikova V. P., Revnova M. O., Listopadova A. P. Irritable bowel syndrome and food allergies in children. Pediatr. 2018, Vol. 9, no. 2, pp. 71-77. (In Russ.)
      19. Grace S, Barnes L, Reilly W, Vlass A, de Permentier P. An integrative review of dietetic and naturopathic approaches to functional bowel disorders.Complement Ther Med. 2018 Dec;41:67-80. DOI: 10.1016/j.ctim.2018.09.004. Epub 2018 Sep 7. Review.
      20. Fedorovich S. V., ZHarin V. A. Food allergy. Minsk: Harvest. 2007; 203: 352. (In Russ.)
      21. Matysheva NN. A new way to determine the specific sensitization of the body to food allergens. Meditsinskaia immunologiia. 2000; 2 (2): 113-252. (In Russ.)
     


    Full text is published :
    Kryukova O. A., Matysheva N. N., Drygin A. N., Khavkin A. I. Food sensitization in patients with diseases of the digestive system. Experimental and Clinical Gastroenterology. 2019;163(3): 4–9. (In Russ.) DOI: 10.31146/1682-8658-ecg-163-3-4-9
    Read & Download full text

    1. V. A. Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia

    Keywords: dysbiosis of the upper digestive tract; rheumatoid arthritis; microbiome; periodontitis

    Abstract: Currently an increasing attention in rheumatology is paid to the identification of diseases at the earliest possible time, the so-called preclinical stages, which may contribute to a more favorable response to therapy and improved prognosis. The etiology of rheumatoid arthritis (RA) is still unknown. One of the possible factors of its development can be periodontal disease (PD) associated with oral dysbiosis. This review examines the relationship between the development of periodontitis and RA, discusses the involvement of the oral microbiome in the common mechanisms of the pathogenesis of PD and RA. Identified cell-mediated mechanisms that cause chronic inflammation and lead to bone resorption and destruction of the joints. The role of PD and P.gingivalis in the process of disruption of autoantigens citrullination is described.

      1. Nasonov E. L., Lila A. M., Galushko E. A., Amirdzhanova V. N. Strategiya razvitiya revmatologii: ot nauchnyh dostizhenij k prakticheskomu zdravoohraneniyu. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2017; 55(4):339-343 (In Russ.)
      2. Erdes Sh.F., Folomeeva O. M., Galushko E. A., Tel’nyh M. Yu. Rezul’taty odnomomentnogo epidemiologicheskogo issledovaniya po opredeleniyu potrebnosti v genno-inzhenernyh biologicheskih preparatah dlya terapii bol’nyh revmatoidnym artritom v real’noj klinicheskoj praktike (IRAKL). Soobshchenie 1. Demograficheskaya, social’naya i kliniko-immunologicheskaya harakteristika rossijskih bol’nyh revmatoidnym artritom. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2009, no. 6, pp.4-13. (In Russ.)
      3. Nasonov E. L., Galushko E. A., Gordeev A. V. Sovremennyj vzglyad na patogenez spondiloartritov - molekulyarnye mekhanizmy. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015; 53 (3):299-307. (In Russ.)
      4. Galushko E. A., Gordeev A. V. Koncepciya «bolezni bar’ernogo organa» v patogeneze spondiloartritov. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(2):199-205. (In Russ.)
      5. Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-14.
      6. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008 Jun;79(6):979-86. doi: 10.1902/jop.2008.070501
      7. Helenius LM, Meurman JH, Helenius I, et al. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand. 2005 Oct;63(5):284-93.
      8. Smolik I, Robinson D, El-Gabalawy HS. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations. Compend Contin Educ Dent. 2009 May;30(4):188-90, 192, 194 passim; quiz 198, 210.
      9. VanWinkelhoff AJ, Loos BG, van der ReijdenWA, et al. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol. 2002;29:1023-8.
      10. Rams TE, Listgarten MA, Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. J Peridontal Res. 2006;41:228-34.
      11. Moen K, Brun JG, Madland TM, et al. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthriti patients. Clin Diagn Lab Immunol. 2003;10:1043-50.
      12. Furuichi Y, Shimotsu A, Ito H, et al. Associations of periodontal status with general health conditions and serum antibody titers for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. J Periodontol. 2003;74:1491-7.
      13. Contreras A, Umeda M, Chen C, et al. Relationship between herpes viruses and adult periodontitis and periodontopathic bacteria. J Periodontol. 1999;70:478-84.
      14. Slots J, Kamma JJ, Sugar C. The herpes virus-Porphyromonas gingivalisperiodontitis axis. J Periodontal Res. 2003; 38:318-23.
      15. Kubar A, Saygun I, Ozdemir A, et al. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J Periodontal Res. 2005;40:97-104.
      16. Martinez-Martinez RE, Abud-Mendoza C, Patino-Marin N, et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol. 2009;36:1004-10.
      17. Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol. 2006;24:656-63.
      18. Rosenstein ED, Greenwald RA, Kushner LJ, et al. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004; 28:311-8.
      19. Hamevose-Poulsen A, Westergaard J, Stoltze K, et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol. 2006;77:280-8.
      20. Marotte H, Farge P, Gaudin P, et al. The association between periodontal disease and joint destraction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destraction. Ann Rheum dis. 2006;65:905-9.
      21. Molitor JA, Alonso A, Wener MH, et al. Moderate to severe adult periodontitis increases risk of rheumatoid arthritis in non-smokers and is associated with elevated ACPA titers: the ARIC study. Arthritis Rheum. 2009;60(Suppl. 10): S433.
      22. Ouédraogo DD, Tiendrébéogo J, Guiguimdé PL, et al. Periodontal disease in patients with rheumatoid arthritis in Sub-Saharan Africa: A case-control study. Joint Bone Spine. 2017 Jan; 84(1):113-114. doi: 10.1016/j.jbspin.2016.02.014. Epub 2016 Mar 17
      23. Ted R. Mikuls, Geoffrey M. Thiele, Kevin D. Deane, et al. Porphyromonas gingivalis and Disease-Related Autoantibodies in Individuals at Increased Risk of Rheumatoid Arthritis. Arthritis & Rheumatism. 2012 Nov; 64(11): 3522-3530. doi 10.1002/art.34595
      24. Nesse W, Westra J, van der Wal JE, et al. The periodontium contains citrullinated proteins, PAD-2 enzymes and HC Gp-39. Arthritis Rheum. 2009;60 (Suppl.10): S434-5.
      25. Soory M. Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention? Curr Drug Metab. 2007;8:750-7.
      26. Berthelot JM, Le Goff B, Maugars Y. Thymic Hassall’s corpuscles, regulatory Tcells, and rheumatoid arthritis. Semin Arthritis Rheum. 2010;39:347-55.
      27. Seror R, Gall-David S, Bonnaure-Mallet M. Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis. Arthritis & Rheumatology. Jul 2015; 67(7):1729-1737. doi 10.1002/art.39118
      28. Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, et al. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis. Arthritis Res Ther. 2013;15: R109.
      29. Pers JO, Saraux A, Pierre R, et al. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol. 2008;79:1645-51.
      30. Kuru B, McCullough MJ, Yilmaz S, Porter SR. Clinical and microbiological studies of periodontal disease in Sjögren syndrome patients. J Clin Periodontol. 2002 Feb;29(2):92-102.
      31. Stein J, Reichert S, Gautsch A, et al. Are there HLA combinations typical supporting for or making resistant against aggressive and/ or chronic periodontitis? J Periodontal Res. 2003;38:508-17.
      32. Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol 2010;192:5002-17.
      33. Rams TE, Listgarten MA, Slots J. Utility of 5 major putative periodontal pathogens and selected clinical parameters to predict periodontal breakdown on maintenance care. J Clin Peridontol. 1996;23:346-54.
      34. Van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, et al. Smoking affects the subgingival microflora in periodontitis. J Periodontol. 2001;72:666-71.
      35. Pers JO, d’Arbonneau F, Devauchelle-Pensec V, et al. Is periodontal disease mediated by salivary BAFF in Sjögren’s syndrome? Arthritis Rheum. 2005 Aug;52(8):2411-4.
      36. Mayer Y, Balbir-Gurman A, Machtei EE. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009 Sep; 80: 1414-20.
      37. Coat J, Demoersman J, Beuzit S, et al. Anti-B lymphocyte immunotherapy is associated with improvement of periodontal status in subjects with rheumatoid arthritis. J Clin Periodontol. 2015;42:817-23, http://dx.doi.org/10.1111/jcpe.12433.
      38. Kobayashi T, Okada M, Ito S, et al. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol. 2014;85:57-67, http://dx.doi.org/10.1902/jop.2013.120696.
     


    Full text is published :
    Gordeev A. V., Galushko E. A., Savushkina N. M. Dysbiosis of the upper digestive tract — a harbinger of rheumatoid arthritis? Experimental and Clinical Gastroenterology. 2019;163(3): 10–15. (In Russ.) DOI: 10.31146/1682-8658-ecg-163-3-10-15
    Read & Download full text